Citations for: Paris, F.; Balaguer, P.; Rimbault, F.; Gaspari, L.; Sultan, C. Molecular Action of Norgestimate: New Developments. Gynecol. Endocrinol. 2015, 31 (6), 487–490.

Entry Type
Name
Value
Parent Entry
Pharmacology Data Field
Progesterone Receptor Activity
Partial agonist
Norgestimate (API)
Pharmacology Data Field
Estrogen Receptor Activity
Antagonist (Ruan, Lello). Selective agonist for ERα (Paris).
Norgestimate (API)
Pharmacology Data Field
Glucocorticoid Receptor Activity
Pronounced as "unknown" by Stanczyk in 2013, but previously claimed as not active (Ruan, Lello). Recently (2015) defined as full antagonist with low affinity (Paris).
Norgestimate (API)
Pharmacology Data Field
Mineralocorticoid Receptor Activity
Varies: Full antagonist with moderate activity (Paris). No activity (Ruan, Lello).
Norgestimate (API)
Pharmacology Data Field
Progesterone Receptor Activity
Partial agonist
Norelgestromin (API)
Pharmacology Data Field
Estrogen Receptor Activity
Selective agonist for ERα
Norelgestromin (API)
Pharmacology Data Field
Glucocorticoid Receptor Activity
Antagonist with low affinity
Norelgestromin (API)
Pharmacology Data Field
Mineralocorticoid Receptor Activity
Antagonist with moderate affinity
Norelgestromin (API)